AR062925A1 - Metodo para fabricar tabletas que contienen agentes farmacologicamente activos - Google Patents

Metodo para fabricar tabletas que contienen agentes farmacologicamente activos

Info

Publication number
AR062925A1
AR062925A1 ARP070104166A ARP070104166A AR062925A1 AR 062925 A1 AR062925 A1 AR 062925A1 AR P070104166 A ARP070104166 A AR P070104166A AR P070104166 A ARP070104166 A AR P070104166A AR 062925 A1 AR062925 A1 AR 062925A1
Authority
AR
Argentina
Prior art keywords
pharmacologically active
active agents
tablets containing
containing pharmacologically
manufacturing tablets
Prior art date
Application number
ARP070104166A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR062925A1 publication Critical patent/AR062925A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un método para mejorar las propiedades físicas de una forma de dosificacion oral solida, en especial una tableta, utiliza un lubricante externo durante el proceso de compactacion. La forma de dosificacion oral solida comprende un agente farmacologicamente activo, por ejemplo una proteína o polipéptido, y un agente de suministro. Empleando el método, se mejoran las propiedades de la tableta, tales como dureza, tiempo de desintegracion, y disolucion.
ARP070104166A 2006-09-22 2007-09-20 Metodo para fabricar tabletas que contienen agentes farmacologicamente activos AR062925A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82659706P 2006-09-22 2006-09-22

Publications (1)

Publication Number Publication Date
AR062925A1 true AR062925A1 (es) 2008-12-17

Family

ID=39227036

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104166A AR062925A1 (es) 2006-09-22 2007-09-20 Metodo para fabricar tabletas que contienen agentes farmacologicamente activos

Country Status (5)

Country Link
AR (1) AR062925A1 (es)
CL (1) CL2007002724A1 (es)
PE (1) PE20080845A1 (es)
TW (1) TW200820993A (es)
WO (1) WO2008039351A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2651398T3 (pl) 2010-12-16 2018-05-30 Novo Nordisk A/S Stałe kompozycje zawierające agonistę GLP-1 i sól kwasu N-(8-(2-hydroksybenzoilo)amino)kaprylowego
CN103619175B (zh) 2011-04-12 2016-08-17 诺沃—诺迪斯克有限公司 双酰化glp-1衍生物
TR201903918T4 (tr) 2012-03-22 2019-04-22 Novo Nordisk As Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
HRP20231060T1 (hr) 2012-03-22 2023-12-22 Novo Nordisk A/S Pripravci peptida glp-1 i njihova priprava
JP6356660B2 (ja) 2012-03-22 2018-07-11 ノヴォ ノルディスク アー/エス 送達剤を含む組成物およびその調製
CN104487056A (zh) 2012-06-20 2015-04-01 诺和诺德A/S(股份有限公司) 包含肽和递送剂的片剂制剂
EP3746111B1 (en) 2018-02-02 2023-07-19 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2327655C (en) * 1998-04-08 2010-03-09 Kyowa Hakko Kogyo Co., Ltd. Tablet production method and tablet
DE602004023093D1 (de) * 2003-07-11 2009-10-22 Novartis Ag N mit einem abgabemittel in mikronisierter form

Also Published As

Publication number Publication date
WO2008039351A2 (en) 2008-04-03
CL2007002724A1 (es) 2008-05-16
PE20080845A1 (es) 2008-08-13
TW200820993A (en) 2008-05-16
WO2008039351A3 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
AR062925A1 (es) Metodo para fabricar tabletas que contienen agentes farmacologicamente activos
CY1118661T1 (el) Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
CR10349A (es) Tabletas de paracetamol de liberacion rapida
GT201300309A (es) Liberación modificada de 4-metil-3-[[4-(3-piridinil)-2- pirimidinil]-amino]-n-[5-(4-metil -1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida solubilizada utilizando ácidos orgánicos
MY150626A (en) Fast dissolving solid dosage form
ECSP088490A (es) Forma farmacéutica oral que contiene como principios activos un inhibidor de la bomba de protones junto con ácido acetilsalicílico
ECSP066584A (es) Procedimiento para la producción de una composición farmacéutica sólida de administración oral
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
AR062644A1 (es) Tecnologia de suministro programable flotante
RS52831B (en) THIN BUPRENORPHINE TILES FOR DRUG REPLACEMENT THERAPY
PE20140854A1 (es) Formas de dosificacion farmaceutica
PE20140255A1 (es) Tableta dispersable en forma oral
UY30535A1 (es) Composicion comprendiendo farmacos antirretrovirales y al menos un polimero insoluble en agua, proceso de preparacion y aplicaciones.
NZ595467A (en) Sublingual pharmaceutical composition comprising a neutral oil
CY1114190T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
AR063538A1 (es) Tratamiento de la enfermedad de parkinson
CO6640264A2 (es) Combinación de gránulos cargados activos con activos adicionales
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
MY191875A (en) Solid dosage form
PE20110943A1 (es) Formulacion oral solida de alisquireno
TR200900879A2 (tr) Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
PE20130147A1 (es) Combinacion farmaceutica de teobromina y un agente antitusivo no opioide
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
IL250852B (en) Periodontal preparation
PE20110925A1 (es) Formulacion galenica que comprende alisquireno y proceso para su preparacion mediante granulacion de extrusion fundida

Legal Events

Date Code Title Description
FB Suspension of granting procedure